Yan Moore's most recent trade in Omega Therapeutics Inc was a trade of 110,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 7, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Omega Therapeutics Inc | Yan Moore | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Omega Therapeutics Inc | Yan Moore | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 55,000 | 55,000 | - | - | Option (Right to Buy) | |
| Omega Therapeutics Inc | Yan Moore | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 477,715 | 477,715 | - | - | Option (Right to Buy) |